Gene Therapy Forum 2026 conference encourages researchers and practitioners to submit original contributions.
// SCIENTIFIC SESSION
Key Topics
Human Gene Therapy
Genome Editing & Gene Engineering
Cell Therapy & Immune Engineering
Regenerative Medicine & Stem Cell Biology
Tissue Engineering & Advanced Biomaterials
Artificial Intelligence & Digital Innovation in Advanced Therapies
Precision Medicine & Rare Diseases
Manufacturing, Translation & Commercialization
Regulatory Science & Clinical Development
Emerging Therapeutic Technologies
Abstract Submission deadline:June 30, 2026
Abstract Submission
Abstract Submission Guidelines
Overview of Abstract Submission and Evaluation Process:
Abstracts submitted to the conference should be written in English only.
Abstracts should be submitted as per the template available above.
Authors can submit their abstracts in Doc, Docx and Pdf format.
Any act of plagiarism is totally unacceptable.
Each abstract should be contains about 500 words, 400 abstract and 100 biography.
The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission.
The type of presentation should be nominated while submitting the abstract.
The abstract submission should be made via conference website only.
Submissions not meeting these guidelines risk rejection without consideration of their merits.
Notification of acceptance or rejection of the scientific committee will be given after a week of submission.
All accepted abstracts will be published in the conference proceedings and the proceedings book will be distributed to all the conference attendees at the registration desk on the day of the conference.